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In modern system of medicine, Madhumeha can be 
compared to Diabetes mellitus, which is known as 
“Richman’s disease” particularly, because a person 
who is able to enjoy the pleasure of life without any 
perceptible exercise is usually affected with this 
disease. The importance of over nutrition is shown by 
the fact that, above the age of 40 years, 80% of the 
people developing diabetes is considerably over 
weight. So obesity is the risk factor for the Diabetes 
mellitus. 
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Madhumeha is one among the twenty obstinate 
urinary disorders explained under the heading of 
Prameha. For all types of Prameha Kapha Dosha is the 
key factor.
[1]
 Ayurveda advocates two kinds of 
treatment measures, which represent the end-phase 
of all the treatment processes, namely Samshodhana 
(Purificatory or Eliminatory) and Samshamana 
(Pacificatory) of which the former is given the first 
place. The vitiated Doshas (Malas), which are 
eliminated from the Urdhwamarga i.e. by mouth is 
called Vamana, through Adhomarga (Guda) is called 
Virechana, both are together called as Virechana.  
In Ayurveda several treatment modalities are there, 
among these Vamana and Virechana have great 
importance in the treatment of Madhumeha (NIDDM) 
with good body strength.
[2]
 These therapies are 
supposed to bring the blood sugar to its normal level, 
preventing the further complications.    
METHODOLOGY 
Research Design:  It is a Comparative clinical trial. 
Patients were assigned into 2 groups.  
A B S T R A C T  
Introduction: Even though the scientific world has conducted extensive studies on Madhumeha but 
couldn’t find a safe and effective therapy or medicine for this disease, in Ayurveda we offer several 
treatment modalities. In the treatment of Sthoola Madhumeha, Vamana and Virechana therapies are 
good result oriented, controls the blood sugar level and prevent further complications without any side 
effects. Vamana and Virechana Karmas are advised in Madhumeha patients having good body 
strength and those who are Sthoola. Objectives: To evaluate the comparative effect of Vamana and 
Virechana Karmas in Madhumeha (NIDDM). Methods: This study includes 2 groups, 15 patients in 
each group. In Group-A, 15 patients received Vamana and in Group-B, 15 patients received 
Virechana. Results and Conclusion: In Group A (Vamana), 08 patients got Good response 
(53.33%), 07 patients are got Moderate response (46.66%) and in Group B (Virechana) 03 patients 
got Good response (20%) and 12 patients got Moderate response (80%), no patient had Poor 
response in both the groups. Thus both procedures are having good and lasting results.  
Key words: Samshodhana, Vamana,  Virechana, Madhumeha, Prameha, Diabetes Mellitus.  
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Source of Data: Patients suffering from Madhumeha 
were selected from P.G. S. & R.C, Dept. of 
Panchakarma, O.P.D. of D.G.M. Ayurvedic Medical 
College and Hospital, Gadag by preset inclusion and 
exclusion criteria. 
Sample size and Grouping: A Minimum of 30 patients 
were taken for study, divided in two groups. 
Inclusion criteria  
 Patients having the clinical features of 
Madhumeha. 
 Madhumeha patients with good body strength 
and are fit for Vamana and Virechana Karmas.  
 The patients between the age group of 25 to 65 
years.  
 Irrespective of sex.  
Exclusion criteria 
 Insulin dependent diabetes mellitus (IDDM).  
 Patients suffering with other systemic disorders.  
 Patients with Diabetic complications.  
Plan of study: Shodhana therapy is divided into 
Poorvakarma, Pradhanakarma and Paschatkarma. 
Poorvakarma: For both the Groups - Poorvakarma is 
same. i.e. 
Deepana - Pachana: with Trikatu Churna[3] 3-6 gm, 3 
times a day ½ hr before food, with hot water, till 
Nirama Laskhanas appears.  
Snehapana -  For Snehapana, Dhanwantara Ghrita[4] 
was selected. After attaining appropriate Niramata, 
the Snehapana was started with Hruseeyasi Matra i.e. 
30 ml and gradually increased to 60 ml and 90 ml, 
totally for three days. It is mentioned in classics that 
for Madhumeha Rogis, less Sneha is enough, as 
Kaphotklesha is already there.
[5]
 
Vishrama Kala (Abhyanga and Sweda) -  As Sweda is 
contraindicated in Madhumeha,
[6]
 the patients were 
administered with Abhynaga and Sukoshna Jala 
Snana. For Abhynaga Moorchita Tila Taila
[7]
 was used. 
Vishrama Kala for Vamana is 1 day and for Virechana 
is 3 days. 
Pradhana Karma 
A) Vamana Karma - For Group-A patients. On 5th day 
the patients were given with Vamana Yoga after 
assessing the status of patient’s Koshta, Bala, etc. The 
medicine used was Madanaphaladi Yoga.
[8]
 
B) Virechana Karma - For Group-B patients. On 7th 
day the patients were given with Virechana Yoga after 
assessing the status of patient’s Koshta, Bala, etc. The 




Samsarjana Krama -  in both the groups, Samsarjana 
krama was performed depending upon the Shuddhi.  
Follow up -  Follow up for one month. During this 
period, placebo capsules were given and patients 
were advised to follow the diet, which the patient had 
followed prior to our study.  
Subjective parameters 
1. Prabhoota Mootrata 
2. Avila Mootrata 
3. Kshudhadhikya 
4. Pipasadhikya 
5. Kara-Pada Daha and Suptata 




1. Blood – FBS, PPBS.  
2. Urine – Urine sugar (Fasting and Post Prandial).  
DISCUSSION 
In Madhumeha Samshodhana is advised especially for 
Sthoola and Balavan in order to correct Agni and to 
reduce the Kleda and Medas, which are increased in 
this disease. Charaka has mentioned it as 
Santarpanajanya Vyadhi where Dhatu Parinama is 
mainly affected. Vamana and Virechana are the 
Apatarpana type of Chikitsa, which could be helpful 
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by eliminating vitiated Doshas correcting Srotodushti, 
there by producing Bala and Varna etc. 
1. Both procedures (Vamana and Virechana) mainly 
correct, the impaired Koshta and vitiated Agni. 
2. Both procedures help to expel-out the 
accumulated morbid matters, from all over the 
body. 
3. Both procedures act at micro-cellular level and 
help to maintain the normal physiology of the 
tissues. 
Discussion on probable mode of action of the 
Vamana and Virechana. 
Vamana  
Madhumeha is a Sankledajanya, even though other 
Doshas are involved in the Samprapthi of this disease, 
Kapha is the main factor, especially along with Medas, 
Rasadi Dhatus etc. are involved.  Madhumeha is a 
disease caused by Trishosha, but the main Dosha is 
Kapha. Vamana eliminates excess amount of vitiated 
morbid Kapha, Pitta, Kleda and also Doshas along with 
the Malas, which is very much helpful to clear or 
check the Dhatuparinama and thereby helps in the 
reduction or pacification of the disease. 
Act at micro-cellular level and helps to maintain the 
normal physiology of the tissues. Thus the patients 
suffering with Sthoola Prameha (obese type 2 
diabetes) will attain homeostasis of Dosha, Dhatu and 
Malas and will remain free from the further 
pathological consequences (Insulin resistance) of 
Kapha-Medo Dusthi and Avarana, in the presence of 
Nidanaparivarjana (avoiding the defaults of diet and 
life style). 
Table 1: Showing the incidence and response of 
Samyak Vamana Lakshanas. 






15 100 8 7 
Kramat KPV 
Pravrutti 
14 93.33 8 6 
Swayam 
Avasthana 
15 100 8 7 
Sroto 
Shuddi 
13 86.66 7 6 
Indriya 
Shuddi 
12 80 6 6 
Laghuta  15 100 8 7 
Dourbalya  9 60 3 6 
Virechana 
Virechana is the main line of treatment for Pitta 
Dosha and it is not Viruddha Chikitsa for Vata and 
Kapha Dosha, which are associated in this disease. 
1. Excretion of Pitta (bile) takes place, as a result fat 
metabolism is checked and hence undigested and 
unutilized fat will be excreted out.  
2. Restriction of diet during Snehapana, Virechana 
and Samsarjana Krama helps or brings about 
mobilization of fat from its deposits.  
3. In the treatment of Sthoolamehi reduction of 
weight also have a role.  Above mentioned 
factors are very much helpful in the reduction of 
weight, when there is reduction of weight, then 
insulin resistance will be reduced and as a result 
relative insulin deficiency will also get corrected.  
4. Obesity is an extremely important environmental 
factor in the formation of type –2 diabetes. 
Approximately 80% of types 2 diabetes are 
obese. In this impaired binding is a result of 
decrease in the number of insulin receptors. 
Vamana and Virechana therapies diminishes the 
insulin resistance by the reduction of weight and 
there by reduces the stress on beta cells.  
5. Among the pathological changes which are 
happening in type 2 diabetes the most consistent 
of these changes is probably deposit of amyloid 
which is accompanied by atrophy of the normal 
tissue particularly Islets of epithelial cells. These 
amyloids are fibrillar proteins in various organs 
and tissues, in such that vital functions are 
compromised.  
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Table 2: Showing the incidence and response Samyak 
Virechana Lakshanas. 
Lakshanas  Patients  % G.R M.R 
Sroto Shuddi  10 66.66 1 9 
Indriya Prasannata 11 73.33 3 8 
Shareera Laghuta 15 100 3 12 
Agni Deepti 15 100 3 12 
Anamayatwa  9 60 3 6 
Vatanulomana  13 86.66 3 10 
Vit,P,K,V Pravrutti 15 100 3 12 
The associated disease state may be inflammatory, 
hereditary orneoplastic and deposition can be local, 
generalized or systemic.  In more advanced lesions, 
the Islets are more or less converted to amyloid and 
the reduction in the number of insulin secreting cells 
are more propounded than that of glucagon secreting 
cells.  
Heavy deposition of amyloids itself are rare without 
diabetes.  The amyloids are fat-soluble and when 
Snehapana and Swedana are administered in the 
patient, these amyloids get dissolved in Snehana, as a 
result of Swedana it moves to Koshta and get 
eliminated by Vamana and Virechana Karmas. 
Above said factors may be the reason why Vamana 
and Virechana are effective in Sthoola Madhumehi. 
From this we can assume that Vamana and Virechana 
corrects the Agni and reduces Kleda and Medas which 
are increased in this condition. Modern science also 
agreed the factor that, obesity leads to insulin 
resistance.  
Table 3: Showing the comparative effect of Group-A 
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To compare the mean effect of 2 Groups, the ‘un-
paired t’ test is used, by assuming that; the mean 
effect of 2 Groups after the treatment is same. From 
the analysis, among the Subjective parameters 
Kshudadhikya and Kara-Pada Daha and Suptata 
shows highly significant, as ‘p<0.05’, all other 
parameters shows non-significant after the treatment. 
Among the subjective parameters, except Shareera 
Ghanatwam, all other parameters are less variation in 
group-A, the mean and the variance in the parameter 
Shareera Durghandha is same in both the Groups (by 
comparing mean and SD). 
Among the objective parameters, in the Body weight, 
the mean effect after the treatment is more in Group-
A, with less variation in FBS, PPBS, F.U.Sugar and 
P.P.U. Sugar. 
Over the entire Group-A shows highly significant in all 
the parameters, except in the parameter 
Pipasadhikya, PPBS and P.P.U. Sugar. 
CONCLUSION 
The terms Prameha and Madhumeha are synonyms. 
They indicate the same condition, where in the 
former refers to Prabhoota and Avila Mootrata and 
the latter refers to Tanu and Mootra Madhuryata. 
Though the disease is of Tridoshaja, but Avrita Vata 
and the Bahudrava Shlesma are the main ailments. 
Kapha is the Arambaka Dosha and Vata is the Preraka 
Dosha. Vamana and Virechana Karmas are good and 
effective treatments in Sthoola Madhumeha and also 
showed the lasting results. Compare to Virechana, 
Vamana is more effective and it shows complete 
remission in newly diagnosed cases. Vaigiki Suddhi 
has very little role in assessing the proportion of 
purification and predicting any type of result from it. 
Along with Vamana and Virechana Karmas 
administration of Pathya Ahara Viharas may give 
more effect. Even though severe cases were also 
included in this study, they also shown moderate 
response. So in severe cases of Madhumeha, repeated 
Vamana and Virechana, along with some 
Shamanoushadhis, Pathya Ahara-Viharas may give 
more effect. 
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